Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trading Statement

21st Jul 2016 07:00

RNS Number : 7928E
Constellation Healthcare Tech, Inc
21 July 2016
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

 

21 July 2016

 

Constellation Healthcare Technologies, Inc.

("Constellation", "CHT" or "the Group")

 

Trading Update

 

Constellation Healthcare Technologies, the US-based healthcare services and technology Company, is pleased to announce that, internal unaudited financial Revenue, Cash from Operations and Operating Profit in the first half of 2016 are in line with board expectations for FY 2016. Revenue for the Full Year is expected to be in excess of $126.5 million.

 

The company is now debt free, and continues to win new business organically. This is expected to continue during the rest of the year. The Company is also evaluating a number of acquisition opportunities and will update the market in due course. 

 

Paul Parmar, Chief Executive Officer of Constellation commented, "CHT continues to grow its business organically demonstrating both demand for its services and the strength of the technology suite. The Company is operating in a strong US medical billing market, and the stage is set for a robust first half financial performance in 2016."

 

Enquiries:

 

Constellation Healthcare Technologies

Paul Parmar, Chief Executive Officer

 

c/o Redleaf Communications

+44 (0)20 7382 4730

finnCap - Nominated Adviser and Joint Broker

Julian Blunt / Scott Mathieson

 

+44 (0)20 7220 0500

Stifel - Joint Broker

Jonathan Senior / Ben Maddison

+44 (0)20 7710 7600

 

Redleaf Communications - PR adviser

Charlie Geller / Sam Modlin 

 

+44 (0)20 7382 4730

[email protected]

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZNVGDGVZM

Related Shares:

CHT.L
FTSE 100 Latest
Value8,275.66
Change0.00